ScoreWhy is Pharmaids Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -1.81% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.31
2
Flat results in Sep 25
- INTEREST(9M) At Rs 3.29 cr has Grown at 207.48%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.77%, its profits have fallen by -34%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.42% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.77% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmaids Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pharmaids Pharma
-14.74%
-0.41
46.16%
Sensex
4.45%
0.45
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
28.70%
EBIT Growth (5y)
-1.81%
EBIT to Interest (avg)
-8.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
0.21
Tax Ratio
22.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-25.14%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
3.53
EV to EBIT
-10.24
EV to EBITDA
-11.62
EV to Capital Employed
2.83
EV to Sales
8.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.59%
ROE (Latest)
-31.39%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET SALES(Q)
At Rs 8.61 cr has Grown at 189.4% (vs previous 4Q average
-7What is not working for the Company
INTEREST(9M)
At Rs 3.29 cr has Grown at 207.48%
Loading Valuation Snapshot...
Here's what is working for Pharmaids Pharma
Net Sales - Quarterly
At Rs 8.61 cr has Grown at 189.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 2.98 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
Highest at Rs 8.61 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Pharmaids Pharma
Interest - Latest six months
At Rs 2.28 cr has Grown at 53.02%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
